SCHEMBL4304000

SCHEMBL4304000

COC(=O)C1C[C@@H](NC2CCC2)CN1C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
CCR2 P41597 2/20 0.41
BTK Q06187 1/20 0.41
EPHX1 P07099 1/20 0.39
MMP2 P08253 7/20 0.38
ANPEP P15144 4/20 0.38
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
PTPN1 P18031 1/20 0.37
HSD17B10 Q99714 1/20 0.36
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPC1 O15118 1/20 0.35
FKBP1A P62942 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4303999 1.00 ALDH1A1 (0.43) ALDH1A1CCR2BTKEPHX1MMP2
SCHEMBL2307409 0.90 CCR2 (0.40) ALDH1A1CCR2MMP2ANPEPNR1H2
SCHEMBL29389706 0.90 CCR2 (0.40) ALDH1A1CCR2MMP2ANPEPNR1H2
SCHEMBL2307831 0.90 CCR2 (0.40) ALDH1A1CCR2MMP2ANPEPNR1H2
SCHEMBL2306832 0.89 CCR2 (0.44) ALDH1A1CCR2MMP2ANPEPNR1H2
SCHEMBL1266962 0.89 CCR2 (0.44) ALDH1A1CCR2MMP2ANPEPNR1H2
SCHEMBL4311053 0.88 BTK (0.48) CCR2BTKEPHX1MMP2ANPEP
SCHEMBL4311050 0.88 BTK (0.48) CCR2BTKEPHX1MMP2ANPEP
SCHEMBL4311057 0.88 BTK (0.48) CCR2BTKEPHX1MMP2ANPEP
SCHEMBL2309467 0.88 CCR2 (0.45) ALDH1A1CCR2MMP2ANPEPNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069376-A1 VLA-4 Antagonists MERCK SHARP & DOHME CORP. 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069376-A1 VLA-4 Antagonists VCAM1, SELPLG, ITGB4 ALDH1A1 854/4885CCR2 529/4885BTK 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.